These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31470024)

  • 1. Statins as a free pass: Body mass index and other cardiovascular risk factors among lipid-lowering medication users and nonusers in the California Men's Health Study.
    Sidell MA; Ghai NR; Reynolds K; Jacobsen SJ; Scott R; Van Den Eeden S; Caan B; Quinn VP
    Prev Med; 2019 Dec; 129():105822. PubMed ID: 31470024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipids, lipoproteins, lifestyle, adiposity and fat-free mass during middle age: the Fels Longitudinal Study.
    Schubert CM; Rogers NL; Remsberg KE; Sun SS; Chumlea WC; Demerath EW; Czerwinski SA; Towne B; Siervogel RM
    Int J Obes (Lond); 2006 Feb; 30(2):251-60. PubMed ID: 16247511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low high-density lipoprotein cholesterol is not a risk factor for recurrent vascular events in patients with vascular disease on intensive lipid-lowering medication.
    van de Woestijne AP; van der Graaf Y; Liem AH; Cramer MJ; Westerink J; Visseren FL;
    J Am Coll Cardiol; 2013 Nov; 62(20):1834-41. PubMed ID: 23948286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different time trends of caloric and fat intake between statin users and nonusers among US adults: gluttony in the time of statins?
    Sugiyama T; Tsugawa Y; Tseng CH; Kobayashi Y; Shapiro MF
    JAMA Intern Med; 2014 Jul; 174(7):1038-45. PubMed ID: 24763487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDL-C: role as a risk modifier.
    Barter P
    Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life style and cardiovascular risk factors in the Japanese population--from an epidemiological survey on serum lipid levels in Japan 1990 part 1: influence of life style and excess body weight on HDL-cholesterol and other lipid parameters in men.
    Yamamoto A; Temba H; Horibe H; Mabuchi H; Saito Y; Matsuzawa Y; Kita T; Nakamura H;
    J Atheroscler Thromb; 2003; 10(3):165-75. PubMed ID: 14564086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medications for blood pressure, blood glucose, lipids, and anti-thrombotic medications: relationship with cardiovascular disease and death in adults from 21 high-, middle-, and low-income countries with an elevated body mass index.
    Leong DP; Rangarajan S; Rosengren A; Oguz A; Alhabib KF; Poirier P; Diaz R; Dans AL; Iqbal R; Yusufali AM; Yeates K; Chifamba J; Seron P; Lopez-Lopez J; Bahonar A; Wei L; Bo H; Weida L; Avezum A; Gupta R; Mohan V; Kruger HS; Lakshmi PVM; Yusuf R; Yusuf S
    Eur J Prev Cardiol; 2022 Oct; 29(14):1817-1826. PubMed ID: 35512128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of statin use with cataracts: a propensity score-matched analysis.
    Leuschen J; Mortensen EM; Frei CR; Mansi EA; Panday V; Mansi I
    JAMA Ophthalmol; 2013 Nov; 131(11):1427-34. PubMed ID: 24052188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimising treatment of hyperlipidaemia: Quantitative evaluation of UK, USA and European guidelines taking account of both LDL cholesterol levels and cardiovascular disease risk.
    Soran H; Adam S; Durrington PN
    Atherosclerosis; 2018 Nov; 278():135-142. PubMed ID: 30273874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid-Lowering Medication: A Cohort Study.
    Korhonen MJ; Pentti J; Hartikainen J; Ilomäki J; Setoguchi S; Liew D; Kivimäki M; Vahtera J
    J Am Heart Assoc; 2020 Feb; 9(4):e014168. PubMed ID: 32019405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between Lipid Phenotypes, Overweight, Lipid Lowering Drug Response and KIF6 and HMG-CoA Genotypes in a Subset of the Brisighella Heart Study Population.
    Angelini S; Rosticci M; Massimo G; Musti M; Ravegnini G; Consolini N; Sammarini G; D'Addato S; Rizzoli E; Botbayev D; Borghi C; Cantelli-Forti G; Cicero AF; Hrelia P
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin Treatment Is Associated With a Neutral Effect on Health-Related Quality of Life Among Community-Dwelling Octogenarian Men: The Helsinki Businessmen Study.
    Strandberg TE; Urtamo A; Kähärä J; Strandberg AY; Pitkälä KH; Kautiainen H
    J Gerontol A Biol Sci Med Sci; 2018 Sep; 73(10):1418-1423. PubMed ID: 29659717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attainment of normal lipid levels among high cardiovascular risk patients: pooled analysis of observational studies from the United Kingdom, Sweden, Spain and Canada.
    Ambegaonkar BM; Bash LD; Chirovsky DR; Jameson K; Grant S; Nocea G; Pettersson B; Sazonov V
    Eur J Intern Med; 2013 Oct; 24(7):656-63. PubMed ID: 23953848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
    Isles CG; Paterson JR
    QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthy Lifestyle for Prevention of Premature Death Among Users and Nonusers of Common Preventive Medications: A Prospective Study in 2 US Cohorts.
    Wang K; Li Y; Liu G; Rimm E; Chan AT; Giovannucci EL; Song M
    J Am Heart Assoc; 2020 Jul; 9(13):e016692. PubMed ID: 32578485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factors.
    Dansinger ML; Williams PT; Superko HR; Schaefer EJ
    Lipids Health Dis; 2019 Jul; 18(1):154. PubMed ID: 31311555
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.